These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 23448294)

  • 21. Evaluation of faecal calprotectin as a valuable non-invasive marker in distinguishing gut pathogens in young children with acute gastroenteritis.
    Sýkora J; Siala K; Huml M; Varvařovská J; Schwarz J; Pomahačová R
    Acta Paediatr; 2010 Sep; 99(9):1389-95. PubMed ID: 20412103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal calprotectin: can be used to distinguish between bacterial and viral gastroenteritis in children?
    Duman M; Gencpinar P; Biçmen M; Arslan N; Özden Ö; Üzüm Ö; Çelik D; Sayıner AA; Gülay Z
    Am J Emerg Med; 2015 Oct; 33(10):1436-9. PubMed ID: 26233616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe diarrhoea caused by highly ciprofloxacin-susceptible Campylobacter isolates.
    Feodoroff FB; Lauhio AR; Sarna SJ; Hänninen ML; Rautelin HI
    Clin Microbiol Infect; 2009 Feb; 15(2):188-92. PubMed ID: 19154485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychometric scores and persistence of irritable bowel after Campylobacter concisus infection.
    Nielsen HL; Engberg J; Ejlertsen T; Nielsen H
    Scand J Gastroenterol; 2014 May; 49(5):545-51. PubMed ID: 24646319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Campylobacter enteritis in children in northern Taiwan--a 7-year experience.
    Wang SC; Chang LY; Hsueh PR; Lu CY; Lee PI; Shao PL; Hsieh YC; Yen FP; Lee CY; Huang LM
    J Microbiol Immunol Infect; 2008 Oct; 41(5):408-13. PubMed ID: 19122923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children.
    Chen CC; Huang JL; Chang CJ; Kong MS
    J Pediatr Gastroenterol Nutr; 2012 Nov; 55(5):541-7. PubMed ID: 22699836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T; Langhorst J; Wittkowski H; Becker K; Friedrich AW; Rueffer A; Dobos GJ; Roth J; Foell D
    Gut; 2007 Dec; 56(12):1706-13. PubMed ID: 17675327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Campylobacteriosis and other bacterial gastrointestinal diseases in Sofia, Bulgaria for the period 1987-2008.
    Ivanova K; Marina M; Petrov P; Kantardjiev T
    Euro Surveill; 2010 Jan; 15(4):19474. PubMed ID: 20122383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The susceptibility of Campylobacter concisus to the bactericidal effects of normal human serum.
    Kirk KF; Nielsen HL; Nielsen H
    APMIS; 2015 Mar; 123(3):269-74. PubMed ID: 25627875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging dynamics of human campylobacteriosis in Southern Ireland.
    Bullman S; Corcoran D; O'Leary J; O'Hare D; Lucey B; Sleator RD
    FEMS Immunol Med Microbiol; 2011 Nov; 63(2):248-53. PubMed ID: 22077228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Campylobacter species as a cause of diarrhoea in children in Calcutta.
    Bhadra RK; Dutta P; Bhattacharya SK; Dutta SK; Pal SC; Nair GB
    J Infect; 1992 Jan; 24(1):55-62. PubMed ID: 1548418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High risk of microscopic colitis after
    Nielsen HL; Dalager-Pedersen M; Nielsen H
    Gut; 2020 Nov; 69(11):1952-1958. PubMed ID: 32111632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Campylobacter fetus ssp jejuni: isolation from patients with gastroenteritis.
    Lambe DW; Ferguson DA; Wiener SL; Butzler JP
    South Med J; 1981 Feb; 74(2):157-61. PubMed ID: 7466431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Two New Membrane-Based and Microtiter Plate Enzyme-Linked Immunosorbent Assays for Detection of Campylobacter jejuni in Stools of Bangladeshi Children.
    Schnee AE; Haque R; Taniuchi M; Uddin MJ; Petri WA
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29925645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of Campylobacter species and Arcobacter butzleri in stool samples by use of real-time multiplex PCR.
    de Boer RF; Ott A; Güren P; van Zanten E; van Belkum A; Kooistra-Smid AM
    J Clin Microbiol; 2013 Jan; 51(1):253-9. PubMed ID: 23152553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Campylobacter jejuni/coli in diarrhoea in Ile-Ife, Nigeria.
    Aboderin AO; Smith SI; Oyelese AO; Onipede AO; Zailani SB; Coker AO
    East Afr Med J; 2002 Aug; 79(8):423-6. PubMed ID: 12638844
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and antimicrobial resistance of Campylobacter isolates from humans and chickens in Bahir Dar, Ethiopia.
    Ewnetu D; Mihret A
    Foodborne Pathog Dis; 2010 Jun; 7(6):667-70. PubMed ID: 20482228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of Campylobacter concisus in diarrhoea of immunocompromised patients.
    Aabenhus R; Permin H; On SL; Andersen LP
    Scand J Infect Dis; 2002; 34(4):248-52. PubMed ID: 12064685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Campylobacter jejuni among patients with gastroenteritis: incidence at a reference microbiology laboratory in San Juan, Puerto Rico.
    López Ortiz W; Soliván RA
    P R Health Sci J; 1999 Sep; 18(3):273-6. PubMed ID: 10547872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunoglobulin G response in patients with Campylobacter concisus diarrhea.
    Nielsen HL; Kaakoush NO; Mitchell HM; Nielsen H
    Diagn Microbiol Infect Dis; 2016 Feb; 84(2):151-4. PubMed ID: 26643061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.